Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BMY compared with GSK: revenue, margins and what each company keeps, and the suppliers and customers both name
BMY
Bristol Myers Squibb Co
Change
Mkt cap
Revenue
Revenue
GSK
GSK plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
BMY
Bristol Myers Squibb Co
vs
GSK
GSK plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
BMY
Bristol Myers Squibb Co
Change
62.89
▲
+0.14%
· post 62.89
· delayed
Mkt cap
$128.4B
Revenue
$13.1B
Q3 FY26
Revenue
$48.2B
FY25
GSK
GSK plc
Change
50.59
▼
−1.24%
· post 50.59
· delayed
After hours
Nov 11 '26
delayed
Mkt cap
$110.5B
Revenue
—
Revenue
—
vs
Compare
After hours
Nov 11 '26
delayed
BMY
Bristol Myers Squibb Co
vs
GSK
GSK plc
62.89
▲
+0.14%
post 62.89
delayed
Price
50.59
▼
−1.24%
post 50.59
delayed
$128.4B
Mkt cap
$110.5B
Q3 FY26
$13.1B
Revenue
—
FY25
$48.2B
Revenue
—
Change
Change
BMY
62.89
▲
+0.14%
vs
GSK
50.59
▼
−1.24%
After hours
Nov 11 '26
delayed
Earnings history
last 4 reports each · paired by recency
Method
›
BMY
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.6%
▲
+1.35%
×0.39
Q2 FY26
±3.7%
▲
+2.79%
×0.76
Q1 FY26
±4.1%
▲
+5.21%
×1.27
Feb 5 '26
±3.8%
▲
+3.30%
×0.87
GSK
No earnings history for GSK.
= implied
BMY realized, solid
GSK realized, hatched
One scale, both sides: full bar = 6%
× = |realized| ÷ implied
Source: market data